Santa Monica, CA, United States of America

Adrian Bot

This inventor holds 1 USPTO granted patent. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adrian Bot. Retrieved from https://idiyas.com/inventor/adrian-bot-gg7tm9p8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adrian Bot - Innovator in T Cell Therapy

Introduction

Adrian Bot is a notable inventor based in Santa Monica, CA (US). He has made significant contributions to the field of medical technology, particularly in the area of T cell therapy. His innovative approach aims to enhance the efficacy of treatments for patients in need.

Latest Patents

Adrian Bot holds a patent for "Diagnostic methods for T cell therapy." This invention provides methods of increasing the efficacy of T cell therapy in patients. It includes techniques for identifying patients who would respond well to T cell therapy and conditioning them prior to treatment. The conditioning process involves administering one or more preconditioning agents and identifying biomarker cytokines before the therapy is administered.

Career Highlights

Throughout his career, Adrian Bot has focused on advancing therapeutic methods that improve patient outcomes. His work has been instrumental in developing strategies that personalize T cell therapy, making it more effective for individual patients.

Collaborations

Adrian has collaborated with notable colleagues, including William Go and Jeffrey S Wiezorek. These partnerships have contributed to the development and refinement of his innovative approaches in T cell therapy.

Conclusion

Adrian Bot's contributions to T cell therapy represent a significant advancement in medical technology. His innovative methods have the potential to improve the lives of many patients in need of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…